Jose Gallucci-Neto

Dr. Jose Gallucci-Neto

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2005 in Neurology
Verified
Journal Article
Closed access
PDF file
CMC. G. Mansur
C. G. Mansur
Felipe FregniFelipe Fregni
Felipe Fregni
PBP. S. Boggio
P. S. Boggio
MRMarcelo Riberto
Marcelo Riberto
JGJose Gallucci-Neto
Jose Gallucci-Neto
APA. Pascual-Leone
A. Pascual-Leone
The authors investigated the use of slow-frequency repetitive transcranial magnetic stimulation (rTMS) to the unaffected hemisphere to decrease interhemispheric inhibition of the lesioned hemisphere and improve motor function in patients within 12 months of a stroke. Patients showed a significant decrease in simple and choice reaction time and improved performance of the Purdue Pegboard test with their affected hand after rTMS of the motor cortex in the intact hemisphere as compared with sham rTMS.

1 August 2004 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
Felipe FregniFelipe Fregni
Felipe Fregni
CSC M Santos
C M Santos
MMM L Myczkowski
M L Myczkowski
RRR Rigolino
R Rigolino
JGJose Gallucci-Neto
Jose Gallucci-Neto
MMM A Marcolin
M A Marcolin
Objective: To study the efficacy of 15 Hz repetitive transcranial magnetic stimulation (rTMS) in treating depression in patients with Parkinson’s disease. Methods: 42 patients were enrolled into two groups: group 1, active rTMS (15 Hz rTMS for 10 days) and placebo drug treatment; group 2, sham rTMS and fluoxetine 20 mg/day. A specially designed sham coil was used for sham stimulation. The unified Parkinson’s disease rating scale (UPDRS), activities of daily living (ADL), Hamilton rating scale for depression (HRSD), Beck depression inventory (BDI), and mini-mental state examination (MMSE) were assessed by a rater blinded to treatment arm. Results: HRSD and BDI were improved to the same extent in both groups after two weeks of treatment (38% and 32% for group 1, 41% and 33% for group 2, respectively). At week 8 there was a tendency for worse motor UPDRS scores in group 2 (NS). ADL showed improvement at week 8 only in group 1. MMSE improved in both groups after treatment, but faster in group 1 than in group 2. There were fewer adverse effects in group 1 than in group 2. Conclusions: rTMS has the same antidepressant efficacy as fluoxetine and may have the additional advantage of some motor improvement and earlier cognitive improvement, with fewer adverse effects.

1 March 2021 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
PSPedro Sudbrack-Oliveira
Pedro Sudbrack-Oliveira
MBMarina Zanichelli Barbosa
Marina Zanichelli Barbosa
STSigride Thome-Souza
Sigride Thome-Souza
LRLais Boralli Razza
Lais Boralli Razza
JGJose Gallucci-Neto
Jose Gallucci-Neto
ABAndre R. Brunoni
Andre R. Brunoni

1 April 2008 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
RMRenato Luiz Marchetti
Renato Luiz Marchetti
DKDaniela Kurcgant
Daniela Kurcgant
JGJose Gallucci-Neto
Jose Gallucci-Neto
MBMary Ann von Bismark
Mary Ann von Bismark
LMLiliana Beccaro Marchetti
Liliana Beccaro Marchetti
LFLia Arno Fiore
Lia Arno Fiore

1 June 2005 in Archives of Clinical Psychiatry (São Paulo)
Verified
Journal Article
Open access
PDF file
JGJose Gallucci-Neto
Jose Gallucci-Neto
MTMelissa Garcia Tamelini
Melissa Garcia Tamelini
OFOrestes V. Forlenza
Orestes V. Forlenza
As síndromes demenciais são caracterizadas pela presença de déficit progressivo na função cognitiva, com maior ênfase na perda de memória, e interferência nas atividades sociais e ocupacionais. O diagnóstico diferencial deve, primeiramente, identificar os quadros potencialmente reversíveis, de etiologias diversas, tais como alterações metabólicas, intoxicações, infecções, deficiências nutricionais etc. Nas demências degenerativas primárias e nas formas seqüelares, o diagnóstico etiológico carrega implicações terapêuticas e prognósticas. Sabe-se que o diagnóstico definitivo da maioria das síndromes demenciais depende do exame neuropatológico. Entretanto, uma avaliação clínica cuidadosa incluindo anamnese detalhada, exames físico e neurológico, associado a determinações bioquímicas e de neuroimagem, podem possibilitar maior acurácia no diagnóstico diferencial. Inovações tecnológicas servindo-se de métodos de neuroimagem estrutural e funcional, bem como de técnicas de biologia e genética molecular, têm apresentado perspectivas para o diagnóstico precoce das demências, particularmente da doença de Alzheimer. As diversas etiologias implicadas no desenvolvimento de síndromes demenciais, bem como as respectivas condutas diagnósticas, serão revistas neste artigo. Dementia is a syndrome characterized by progressive impairment of cognitive functions, particularly in memory, which affects social and occupational activities. The differential diagnosis must, firstly, identify potentially treatable causes of cognitive impairment, addressing the different etiologies of reversible dementia such as metabolic alterations, intoxications, CNS infections, and nutritional deficiencies. The correct and early diagnosis of primary degenerative dementia carries therapeutic and prognostic implications, which may attenuate the inevitable cognitive and behavioral deficits. Definitive diagnoses of most primary dementia syndromes rely on post-mortem neuropathological examination. However, a thorough clinical evaluation, including a detailed clinical history, physical and neurological examination, combined with biochemical determinations and neuroimaging, provide a more accurate differential diagnosis. Technological innovations making use of both structural and functional neuroimaging methods, as well molecular biology and molecular genetic techniques, have presented in the recent literature a strong perspective for the early diagnosis of dementia, especially of Alzheimer disease. The different etiologies involved in the development of dementia syndromes, as well as the respective diagnostic conduct, will be reviewed in this article

1 October 2020 in Vaccine
Verified
Journal Article
Closed access
RMRenato Luiz Marchetti
Renato Luiz Marchetti
JGJose Gallucci-Neto
Jose Gallucci-Neto
DKDaniela Kurcgant
Daniela Kurcgant
IPInah Carolina Galatro Faria Proença
Inah Carolina Galatro Faria Proença
LVLeandro da Costa Lane Valiengo
Leandro da Costa Lane Valiengo
LOLucia H. De Oliveira
Lucia H. De Oliveira